👶Pregnancy
Baclofen crosses the placenta. Data are limited, but neonatal withdrawal (increased tone, jitteriness, seizures) has been reported when mothers used baclofen near delivery. For AUD in pregnancy, non-pharmacologic treatments are preferred, and when medication is necessary, other options with more robust pregnancy data are typically considered first. If baclofen must be used, the lowest effective dose and close obstetric and pediatric monitoring are recommended.🤱Breastfeeding
Baclofen appears in breast milk at low levels. Limited case reports have not shown major toxicity, but infant sedation and hypotonia are theoretical risks. For AUD, breastfeeding patients should generally prioritize behavioral treatments and safer medications; if baclofen is used, monitor the infant for poor feeding, excessive sleepiness, or decreased tone.👧Children & Adolescents (Under 18)
Baclofen is not used for alcohol use disorder in children or adolescents. Its pediatric use is primarily for spasticity under specialist care.👴Older Adults (65+)
Older adults are much more sensitive to sedation, confusion, and falls. Start very low, titrate very slowly, cap the maximum dose conservatively, and monitor closely for cognitive changes, gait instability, and delirium.🔬Liver Impairment
Because baclofen is minimally metabolized hepatically, it is sometimes considered in patients with advanced liver disease where naltrexone or disulfiram may be problematic. However, these patients are often medically fragile, and central nervous system side effects can be more dangerous, so dosing and monitoring must be particularly cautious.💧Kidney Impairment
Renal function is crucial: most baclofen is excreted unchanged in urine. In moderate to severe renal impairment, even standard doses can cause profound toxicity (confusion, coma). Dose reductions or avoidance may be necessary; dialysis can help clear baclofen in overdose but does not fully eliminate risk.